Tetra Natural Health (“TNH”) a wholly owned subsidiary of Tetra Bio-Pharma Inc., (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF) today announced that it has submitted two over-the-counter (OTC) DIN applications to Health Canada. The first application, submitted on November 15th, is for the treatment of hemorrhoids. The second application, submitted today, November 26th, is for the temporary relief of aches and pains of muscles and joints associated with backache, lumbago, strains, bruises, sprains and arthritic or rheumatic pain, pain of tendons and ligaments.
Crescita & TetraBio Collaborate to Enhance Delivery of Beta-Caryophyllene